Evaluation of the Association of Urokinase Plasminogen Activator System Gene Polymorphisms with Susceptibility and Pathological Development of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Evaluation of the Association of Urokinase Plasminogen Activator System Gene Polymorphisms with Susceptibility and Pathological Development of Hepatocellular Carcinoma

Published:2010-08-13 Issue:12 Volume:17 Page:3394-3401
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Weng Chia-Jui,Tsai Chiung-Man,Chen Yi-Chen,Hsieh Yi-Hsien,Lin Chiao-Wen,Liu Yu-Fan,Su Shih-Chi,Chen Mu-Kuan,Yang Shun-Fa

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-010-1124-y.pdf

Reference37 articles.

1. Berger DH. Plasmin/plasminogen system in colorectal cancer. World J Surg. 2002;26:767–71.

2. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932–43.

3. Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 2003;22:205–22.

4. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997;72:1–22.

5. Danø K, Rømer J, Nielsen BS, Bjørn S, Pyke C, Rygaard J, Lund LR. Cancer invasion and tissue remodeling—cooperation of protease systems and cell types. APMIS. 1999;107:120–7.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors;Cancer Letters;2023-04

2. Bombyx batryticatus Cocoonase Inhibitor Separation, Purification, and Inhibitory Effect on the Proliferation of SMCC-7721 HeLa-Derived Cells;Evidence-Based Complementary and Alternative Medicine;2022-06-14

3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation;Frontiers in Immunology;2021-12-02

4. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer;Technology in Cancer Research & Treatment;2021-01-01

5. Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients;Bulletin of the National Research Centre;2019-12